EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives

Yue Fan, Yinhui Liu iD, Chenyi Shao, Chunyu Jiang, Lijuan Wu, Jing Xiao, Li Tang iD

International Journal of Molecular Sciences · 07.06.2025 · 26 (12) · 5486

DOI: 10.3390/ijms26125486 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.06.2025. Verfasst von Yue Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microecology, College of Basic Medical Science, Dalian Medical University, Dalian 116041, China. Hauptthemen laut MEDLINE: Probiotics, Gastrointestinal Microbiome, Metabolic Diseases, Drugs, Chinese Herbal. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dalian Medical University Interdisciplinary Research Cooperation Project Team Funding, Dalian Medical University Interdisciplinary Research Cooperation Project Team.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota dysbiosis is intricately linked to metabolic disorders such as obesity, type 2 diabetes mellitus (T2DM), hyperlipidemia, and non-alcoholic fatty liver disease (NAFLD). Traditional Chinese medicine (TCM), particularly when combined with probiotic fermentation, offers a promising therapeutic strategy by modulating microbial balance and host metabolism. This narrative review synthesizes current research on probiotic-fermented herbal bioactives, focusing on their mechanisms in ameliorating metabolic diseases. Probiotic and bioactive compounds (e.g., berberine, polysaccharides) are highlighted for their roles in enhancing intestinal barrier function, regulating microbial metabolites like short-chain fatty acids (SCFAs), and reducing inflammation. Fermentation techniques improve the bioavailability of TCM components while reducing toxicity, as seen in fermented Salvia miltiorrhiza and Rhizoma Coptidis. Despite promising results, challenges include the complexity of microbiota–host interactions and variability in TCM standardization. Future directions emphasize integrating multi-omics technologies and personalized approaches to optimize probiotic-fermented TCM therapies. This review underscores the potential of combining traditional herbal wisdom with modern biotechnology to address metabolic disorders, which pose significant global health challenges, through a “gut microbiota–metabolism” axis. Emerging evidence highlights the critical role of gut microbiota dysbiosis in the pathogenesis of these conditions. TCM has shown promise in modulating gut microbiota to restore metabolic homeostasis. This review synthesizes current research on TCM-derived interventions, such as herbal compounds, probiotics, and fermentation techniques, that target gut microbiota to ameliorate metabolic disorders. We discuss mechanisms of action, including prebiotic effects, enhancement of intestinal barrier function, and regulation of microbial metabolites, while addressing the limitations and future directions of TCM-based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsGastrointestinal MicrobiomeMetabolic DiseasesDrugs, Chinese HerbalHumansFermentationAnimalsMedicine, Chinese Traditional

Stichwörter der Autor:innen

fermentationgut microbiotametabolic diseasesprobioticstraditional Chinese medicine

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Department of Microecology, College of Basic Medical Science, Dalian Medical University, Dalian 116041, China.
  • Department of Oral Pathology, College of Stomatology, Dalian Medical University, Dalian 116041, China.

ORCID-Profile: Yinhui Liu, Li Tang

Förderung

  • Dalian Medical University Interdisciplinary Research Cooperation Project Team Funding
  • Dalian Medical University Interdisciplinary Research Cooperation Project Team

Zitieren

APA

Fan, Y., Liu, Y., Shao, C., Jiang, C., Wu, L., Xiao, J., & Tang, L. (2025). Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives. International Journal of Molecular Sciences, 26(12), 5486. https://doi.org/10.3390/ijms26125486

Vancouver

Fan Y, Liu Y, Shao C, Jiang C, Wu L, Xiao J, et al. Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives. International Journal of Molecular Sciences. 2025;26(12):5486. doi:10.3390/ijms26125486

BibTeX
@article{Fan2025,
  author = {Fan, Yue and Liu, Yinhui and Shao, Chenyi and Jiang, Chunyu and Wu, Lijuan and Xiao, Jing and Tang, Li},
  title = {Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {12},
  pages = {5486},
  doi = {10.3390/ijms26125486}
}
Kostenlos starten →